Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT06640010
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

Key Dates

Start date
Jan 13, 2025
Status verified
Jan 2026
Primary completion
Dec 15, 2026
Completion
Dec 15, 2026

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood sample collection and have their medical records reviewed on study.

Primary Outcome Measure

In vitro measurement of cellular viability in response to chemotherapy [ Time Frame: Blood drawn at enrollment to obtain sample ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Clinical Trials Referral Office
[email protected]
855-776-0015
Nadine Norton, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FL

Related Studies